Zealand Pharma — Februar 2024
-
Tak BSI
-
Korrektion: Jefferies sænker til Sælg var en fejl, nyhedstjeneste har rettet fejlen
-
Zealands anbefaling nedgraderes dobbelt af Danske Bank, men kursmålet hæves 50 pct https://www.proinvestor.com/investornyt/1123590/zealands-anbefaling-nedgraderes-dobbelt-af-danske-bank-men-kursmalet-haeves-50-pct
. -
Zealand Pharmas topchef ser alternativ til GLP-1 som kronjuvelen i porteføljen https://www.proinvestor.com/investornyt/1123602/zealand-pharmas-topchef-ser-alternativ-til-glp-1-som-kronjuvelen-i-portefoljen
-
griner - godt handlet
-
"Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity"
-
Godmorgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind